News and advice

Dan Mohr Dan Mohr

MD&M Minneapolis is underway

MD&M Minneapolis is back under the big domes of the Minneapolis Convention Center. A good show with a decent turnout this year. Opportunities abound.

Read More
Dan Mohr Dan Mohr

NASS 2022 Begins in Chicago

NASS 2022 begins. The mood is positive but cautious among exhibitors as adjustments post Covid and uncertainty in the economy makes themselves felt.

Read More
Dan Mohr Dan Mohr

BIOMEDevice underway in Boston

BIOMEDevice show started today with a great talk by Erika Cheung, the Theranos whistle blower. Middle Branch Partners is there at the show.

Read More
Dan Mohr Dan Mohr

Medical Technology Ireland

One of the best attended of the European shows is Medical Technology Ireland. It is underway this week and Larry Barr is there.

Read More
Dan Mohr Dan Mohr

IMTS in Full Swing

IMTS 2022 is underway in Chicago - bringing new manufacturing technologies to MedTech and Middle Branch Partners is there.

Read More
Dan Mohr Dan Mohr

MD&M West 2022 in Anaheim

Middle Branch Partners was at the MD&M West show in Anaheim, California this week. Turnout was surprisingly strong showing the strength of the MedTech industry in the face of global challenges.

Read More
Dan Mohr Dan Mohr

AAOS in Full Swing

AAOS 2022 is back to its normal cadence, a March show around Spring Break. But there is no Spring Break in Chicago, with cloudy skies, rain and wind. It is the Windy City after all.

Read More
Dan Mohr Dan Mohr

AAOS Day 0: Cocktails at the Club

Kick-off reception for AAOS 2022 at the Union League Club, Chicago. Great attendance and a great speaker! Front, left to right, David Anderson, Managing Director Capital One Medical Devices & Products and Albert DaCosta, Founder and CEO Paragon 28 - the evening’s speaker.

Read More
Dan Mohr Dan Mohr

Orthopedic Sales Unlikely to See Upside in 4Q Earnings Results

Mike Evers of Orthoworld discusses how the orthopedic market finds itself in familiar territory in early 2022, with COVID infections surging to record levels. While we await fourth-quarter and full-year results from orthopedic companies, we'll summarize below our expectations and questions for the market as it enters the third year of disruption from the pandemic.

Content republished with permission from ORTHOWORLD® Inc.

Read More